Graftys is active in medtech’s market, is one of the world leaders in synthetic resorbable orthopaedic cements, with a pipeline of 2 marketed products (registered in 27 countries).

Following to the capital increase structured by TheClubDeal, Graftys has relocated its headquarters in Wallonia from France while refocusing its French unit (located in Aix-en-Provence) around its core cement production skills.